[Table/Fig-3]:
Parameters for Prevalence calculation (Pe) from screening tests among Population 18 years of age and above.
| Against gold standard of fasting (≥7.0mmol/L or 126 mg/dl and above) True Prevalence (among above 18 y of age=4.58%) |
Against gold standard of PP (≥11.1 mmol/L or 200 mg/dl and above) True Prevalence (among above 18 y of age=4.58%) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Screening test | Cut off | Se | Sp | P(A)* | (Pe)** | Cut-off | Se | Sp | P(A)* | P(e)** |
| Urine Sugar (double void) | 180 mg/dl | 65.2 | 99.9 | 0.03 | 4.45% | 180 mg/dl | 84.8 | 99.7 | 0.04 | 4.42% |
| Canrisk | 7 | 89.1 | 53.2 | 0.48 | 4.49% | 7 | 82.6 | 52.9 | 0.48 | 4.5% |
| MDRF-IDRS | 60 | 52.2 | 68.6 | 0.32 | 4.3% | 60 | 52.2 | 68.6 | 0.32 | 4.3% |
Where, P(A)* is prevalence determined by screening test and P(e)** is estimated prevalence by each of the screening test.